---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-134476"
form_type: "8-K"
ticker: "SCYX"
cik: "0001178253"
company_name: "SCYNEXIS INC"
filed_at: "2026-03-31T23:59:59+00:00"
generated_at: "2026-05-15T08:06:33.255092+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "low"
source: SEC EDGAR
---

# SCYNEXIS discusses asset acquisition in corporate update call

## Summary
- Conference call held on March 31, 2026 covering an asset acquisition transaction.
- Slide presentation filed as Exhibit 99.1; no financial terms disclosed in this 8-K.
- Company's deck highlights focus on severe rare disease solutions.
- No specific revenue, earnings, or closing timeline provided.

## SEC filing metadata
- accession: 0001193125-26-134476
- form_type: 8-K
- ticker: SCYX
- cik: 0001178253
- company_name: SCYNEXIS INC
- filed_at: 2026-03-31T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1178253/000119312526134476/0001193125-26-134476-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1178253/000119312526134476/d114312d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-134476
- JSON: https://secwatch.observer/filing/0001193125-26-134476.json
- Plain text: https://secwatch.observer/filing/0001193125-26-134476.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.